Clinuvel Pharmaceuticals Limited (CUV) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2013, Pages: 39

Summary

Clinuvel Pharmaceuticals Limited (Clinuvel Pharmaceuticals), formerly EpiTan Limited, is a biopharmaceutical company. The company carries out the development of photoprotective drug called Scenesse (afamelanotide) as a preventive treatment for a range of ultra violet (UV) and light related skin disorders. Scenesse provides skin protection against UV radiation (UVR) as it stimulates the body’s natural ability to produce melanin, the dark pigment of the skin, which is known to have photoprotective properties. The company completed the testing of Scenesse in Phase II and III trials in Europe, and the US.

This comprehensive SWOT profile of Clinuvel Pharmaceuticals Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Clinuvel Pharmaceuticals Limited - Key Facts
Clinuvel Pharmaceuticals Limited - Key Employees
Clinuvel Pharmaceuticals Limited - Key Employee Biographies
Clinuvel Pharmaceuticals Limited - Major Products and Services
Clinuvel Pharmaceuticals Limited - Pharmaceutical Pipeline Products Data
Clinuvel Pharmaceuticals Limited, Pipeline Products by Therapy Area
Clinuvel Pharmaceuticals Limited, Pipeline Products by Development Phase
Clinuvel Pharmaceuticals Limited - Medical Equipment Pipeline Products Data
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage
Clinuvel Pharmaceuticals Limited - History
Clinuvel Pharmaceuticals Limited - Company Statement
Clinuvel Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Clinuvel Pharmaceuticals Limited - Business Description
Clinuvel Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
Clinuvel Pharmaceuticals Limited - Strengths
Strength - Orphan Drug Destination
Strength - Proprietary Drug - Scenesse (Afamelanotide)
Strength - Strong Patent Portfolio
Clinuvel Pharmaceuticals Limited - Weaknesses
Weakness - Lack of Diversified Product Pipeline
Weakness - Negative Profitability
Clinuvel Pharmaceuticals Limited - Opportunities
Opportunity - Strategic Alliances
Opportunity - Emerging Markets
Opportunity - Potential Australian Market
Clinuvel Pharmaceuticals Limited - Threats
Threat - Industry Consolidation
Threat - Competitive Pressures
Threat - Government Regulations
Clinuvel Pharmaceuticals Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Clinuvel Pharmaceuticals Limited, Key Facts
Clinuvel Pharmaceuticals Limited, Key Employees
Clinuvel Pharmaceuticals Limited, Key Employee Biographies
Clinuvel Pharmaceuticals Limited, Major Products and Services
Clinuvel Pharmaceuticals Limited, Number of Pipeline Products by Therapy Area
Clinuvel Pharmaceuticals Limited, Number of Pipeline Products by Development Stage
Clinuvel Pharmaceuticals Limited, Pipeline Products By Therapy Area and Development Phase
Clinuvel Pharmaceuticals Limited Number of Pipeline Products by Equipment Type
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type
Clinuvel Pharmaceuticals Limited Number of Pipeline Products by Development Stage
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage
Clinuvel Pharmaceuticals Limited, History
Clinuvel Pharmaceuticals Limited, Subsidiaries
Clinuvel Pharmaceuticals Limited, Key Competitors
Clinuvel Pharmaceuticals Limited, Ratios based on current share price
Clinuvel Pharmaceuticals Limited, Annual Ratios
Clinuvel Pharmaceuticals Limited, Interim Ratios
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Clinuvel Pharmaceuticals Limited, Pipeline Products by Therapy Area
Clinuvel Pharmaceuticals Limited, Pipeline Products by Development Phase
Clinuvel Pharmaceuticals Limited Pipeline Products by Equipment Type
Clinuvel Pharmaceuticals Limited Pipeline Products by Development Stage
Clinuvel Pharmaceuticals Limited, Performance Chart (2008 - 2012)
Clinuvel Pharmaceuticals Limited, Ratio Charts
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Clinuvel Pharmaceuticals Limited, Medical Equipment, Deals by Type, 2007 to YTD 2013

Immune System Therapeutics Ltd.
EnGeneIC Ltd
Marshall Edwards, Inc.
biosensis Pty Ltd
Circadian Technologies Limited

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• The Global UAV Payload Market 2012-2022